6568 — KNC Laboratories Co Income Statement
0.000.00%
Last trade - 00:00
- ¥11bn
- ¥11bn
- ¥9bn
- 71
- 79
- 34
- 69
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,291 | 6,348 | 6,029 | 7,441 | 8,628 |
Cost of Revenue | |||||
Gross Profit | 2,347 | 1,730 | 1,760 | 2,107 | 3,304 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,040 | 5,793 | 5,485 | 6,530 | 6,491 |
Operating Profit | 1,250 | 555 | 544 | 911 | 2,137 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,296 | 705 | 586 | 917 | 2,172 |
Provision for Income Taxes | |||||
Net Income After Taxes | 936 | 518 | 400 | 643 | 1,543 |
Net Income Before Extraordinary Items | |||||
Net Income | 936 | 518 | 400 | 643 | 1,543 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 936 | 518 | 400 | 643 | 1,543 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 120 | 61.3 | 59.6 | 99.6 | 203 |
Dividends per Share |